Video Link: https://www.youtube.com/watch?v=XuEotMx8dP4

29-03-2012 12:24 More LXBN TV interviews at: lxbn.lexblog.com While talk this week of course focuses on the oral arguments in the Affordable Care Act case, the Supreme Court last week ruled in a very important and influential intellectual property case. In Mayo Collaborative Services v. Prometheus Laboratories, Inc., the court ruled that the patent Prometheus had obtained for correlations between blood test results and patient health is not eligible for a patent because it incorporates laws of nature. Not only does this have a big impact on the medical community, but also another major case—the Myriad "gene patenting" case. To explain the background of Mayo v. Prometheus, whether or not these types of patents slow medical research and what this means for the Myriad case, we bring in Foley & Lardner Partner Antoinette Konski, who has covered this case exceptionally on the Personalized Medicine Bulletin-- http://www.personalizedmedicinebulletin.com

Read the original post:
Mayo v. Prometheus and Its Impact on Myriad "Gene Patenting" Case—Antoinette Konski - Video

Comments are closed.